Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma
Blood biomarkers to detect Alzheimer disease in primary care and secondary care
Changes in Alzheimer disease blood biomarkers and associations with incident all-cause dementia
Cryoglobulinemia — one name for two diseases
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
Hairy-cell leukemia (NEJM review)
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation
How do we manage hyperhemolysis syndrome?
How I treat acute venous thromboembolism in patients with brain tumors
The impact of hematology electronic consultations on the management of iron deficiency
The intestinal microbiota and cellular therapy: implications for impact and mechanisms
New insights into the biology of T-cell lymphomas
Novel functions for von Willebrand factor
A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas
Revisiting the full blood count: circulating blood cells and their role in coagulation
Blood (12th Sep-31st Oct); British Journal of Haematology (Oct); European Journal of Haematology (Nov); JAMA (Oct); NEJM (Oct); Transfusion (Oct); Transfusion Medicine (Oct)
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy
Chronic lymphocytic leukaemia (Lancet seminar review)
Cord blood banking: experts raise concern over claims made for stem cell applications
Current challenges in conditioning regimens for MDS transplantation
Dismantling relapsed/refractory mantle cell lymphoma
Elevating fetal hemoglobin: recently discovered regulators and mechanisms
Evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma
The global blood donation index: an imperfect measure of transfusion need
Gut microbiome composition and dysbiosis in immune thrombocytopenia: a review of literature
Hemoglobin Bart’s hydrops fetalis: charting the past and envisioning the future
Hot under the clot: venous thrombogenesis is an inflammatory process
Household water lead and hematologic toxic effects in chronic kidney disease
How I diagnose and treat organizing pneumonia in hematopoietic cell transplant recipients
How I treat bleeding in hereditary hemorrhagic telangiectasia
IL-1 in aging and pathologies of hematopoietic stem cells
Immune thrombocytopenia: pathophysiology and impacts of Romiplostim treatment
Iron, hemochromatosis genotypes, and risk of infections
Momelotinib for the treatment of myelofibrosis
A moonlighting job for α-globin in blood vessels
New frameworks for hematopoiesis derived from single-cell genomics
Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders
Procoagulant platelets promote immune evasion in triple-negative breast cancer
Blood (11th July-5th Sep); Blood Reviews (Sep); BMJ, The (Jul); JAMA Internal Medicine (Jul); Lancet, The (Aug-Sep)
Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia 10.1016/j.blre.2024.101208
Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease 10.1182/blood.2023021174
Bone marrow niches for hematopoietic stem cells: life span dynamics and adaptation to acute stress 10.1182/blood.2023023788
Current status and prospect of anti-amyloid fibril therapy in AL amyloidosis 10.1016/j.blre.2024.101207
DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies 10.1182/blood.2023019963
Early palliative care in haematological malignancies 10.1136/spcare-2024-004812
Escape from T-cell–targeting immunotherapies in acute myeloid leukemia 10.1182/blood.2023019961
Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM): a stepped-wedge cluster-randomised trial 10.1016/S0140-6736(24)01085-7
Evidence for antigen presentation by human neutrophils 10.1182/blood.2023023444
Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis 10.1182/blood.2023022736
How I treat long-term survivors of childhood acute leukemia 10.1182/blood.2023019804
How I treat the co-occurrence of venous and arterial thromboembolism: anticoagulation, antiplatelet therapy, or both? 10.1182/blood.2023021638
How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia 10.1182/blood.2022017235
Ivosidenib with azacitidine for untreated acute myeloid leukaemia with an IDH1 R132 mutation (new NICE guideline TA979)
Malignant progression of preleukemic disorders 10.1182/blood.2023020817
Short-term and long-term survival in patients with prevalent haemodialysis—an integrated prognostic model: external validation 10.1136/spcare-2022-003916
Tricking the trickster: precision medicine approaches to counteract leukemia immune escape after transplant 10.1182/blood.2023019962
Voxelotor for treating haemolytic anaemia caused by sickle cell disease (new NICE guideline TA981)
What clinicians should know about surrogate end points in hematologic malignancies 10.1182/blood.2023022269
Blood (25th Apr-4th Jul); Blood Reviews (Jul); BMJ Supportive and Palliative Care (Jun); Lancet, The (Jul); NICE website (Jun)
The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.